
	March 29, 2025
Unaudited Condensed Consolidated Balance Sheet:	As Previously Reported		Adjustments (B)			As Restated
Assets
Current Assets
Cash and cash equivalents	$	30,732	$	—		$	30,732
Accounts receivable, net of allowance for credit losses of $2,122 at March 29, 2025	119,154		(1,307)			117,847
Contract assets	210,897		(434)			210,463
Inventories	197,414		595			198,009
Production cost of contracts	6,699		—			6,699

Other current assets	13,641		714			14,355

Total Current Assets	578,537		(432)			578,105
Property and Equipment, Net of Accumulated Depreciation of $197,524 at March 29, 2025	109,075		—			109,075
Operating Lease Right-of-Use Assets	26,423		—			26,423
Goodwill	244,600		—			244,600
Intangibles, Net	145,403		—			145,403
Deferred Income Taxes	4,245		167		(A)	4,412
Other Assets	20,332		—			20,332
Total Assets	$	1,128,615	$	(265)		$	1,128,350
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable	$	80,290	$	—		$	80,290
Contract liabilities	37,496		—			37,496
Accrued and other liabilities	34,365		(1,677)		(A)	32,688
Operating lease liabilities	8,721		—			8,721
Current portion of long-term debt	12,500		—			12,500

Total Current Liabilities	173,372		(1,677)			171,695
Long-Term Debt, Less Current Portion	229,920		—			229,920
Non-Current Operating Lease Liabilities	19,103		—			19,103

Other Long-Term Liabilities	13,213		2,352		(A)	15,565
Total Liabilities	435,608		675			436,283
Commitments and Contingencies
Shareholders’ Equity
Common Stock - $0.01 par value; 35,000,000 shares authorized; 14,868,305 shares issued and outstanding at March 29, 2025	149		—			149

Additional Paid-In Capital	219,842		17,987		(A)	237,829
Retained Earnings	463,986		(18,927)			445,059
Accumulated Other Comprehensive Income	9,030					9,030
Total Shareholders’ Equity	693,007		(940)			692,067
Total Liabilities and Shareholders’ Equity	$	1,128,615	$	(265)		$	1,128,350


	Three Months Ended March 29, 2025
Unaudited Condensed Consolidated Statement of Income:	As Previously Reported		Adjustments (B)			As Restated
Net Revenues	$	194,114	$	(1,633)		$	192,481
Cost of Sales	142,517		(487)			142,030
Gross Profit	51,597		(1,146)			50,451
Selling, General and Administrative Expenses	34,594		10,456		(A)	45,050
Restructuring Charges	426		—			426
Operating Income	16,577		(11,602)			4,975
Interest Expense	(3,263)		—			(3,263)



Income Before Taxes	13,314		(11,602)			1,712
Income Tax Expense	2,803		(2,493)		(A)	310
Net Income	$	10,511	$	(9,109)		$	1,402
Earnings Per Share
Basic earnings per share	$	0.71				$	0.09
Diluted earnings per share	$	0.69				$	0.09
Weighted-Average Number of Common Shares Outstanding
Basic	14,856					14,856
Diluted	15,177					15,177


	Three Months Ended March 29, 2025
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss):	As Previously Reported		Adjustments		As Restated
Net Income	$	10,511	$	(9,109)	$	1,402
Other Comprehensive (Loss) Income, Net of Tax:
Amortization of actuarial losses and prior service costs, net of tax of $6 for the three months ended March 29, 2025.	20		—		20

Change in net unrealized losses on cash flow hedges, net of tax benefit of $715 for the three months ended March 29, 2025.	(2,374)		—		(2,374)
Other Comprehensive Loss, Net of Tax	(2,354)		—		(2,354)
Comprehensive Income (Loss)	$	8,157	$	(9,109)	$	(952)


	Three Months Ended March 29, 2025
Unaudited Condensed Consolidated Statement of Cash Flows:	As Previously Reported		Adjustments (B)			As Restated
Cash Flows from Operating Activities
Net Income	$	10,511	$	(9,109)	(A)	$	1,402
Adjustments to Reconcile Net Income to
Net Cash Provided by Operating Activities:
Depreciation and amortization	8,584		—			8,584
Non-cash operating lease cost	2,194		—			2,194



Stock-based compensation expense	5,347		10,387		(A)	15,734
Deferred income taxes	(1,296)		—			(1,296)

Recovery of credit losses	(54)		—			(54)



Other	307		—			307
Changes in Assets and Liabilities:
Accounts receivable	(9,384)		1,308			(8,076)
Contract assets	(10,313)		325			(9,988)
Inventories	(533)		(486)			(1,019)
Production cost of contracts	(16)		—			(16)
Other assets	3,622		(709)			2,913
Accounts payable	4,929		—			4,929
Contract liabilities	3,051		—			3,051
Operating lease liabilities	(1,918)		—			(1,918)
Accrued and other liabilities	(14,260)		(1,716)		(A)	(15,976)
Net Cash Provided by Operating Activities	771		—			771
Cash Flows from Investing Activities
Purchases of property and equipment	(4,815)		—			(4,815)





Net Cash Used in Investing Activities	(4,815)		—			(4,815)
Cash Flows from Financing Activities


Borrowings from senior secured revolving credit facility	15,000		—			15,000
Repayments of senior secured revolving credit facility	(15,000)		—			(15,000)


Repayments of other debt	(96)		—			(96)






Net cash paid upon issuance of common stock under stock plans	(2,267)		—			(2,267)
Net Cash Used in Financing Activities	(2,363)		—			(2,363)
Net Decrease in Cash and Cash Equivalents	(6,407)		—			(6,407)
Cash and Cash Equivalents at Beginning of Period	37,139		—			37,139
Cash and Cash Equivalents at End of Period	$	30,732	$	—		$	30,732

Note A: The correction for the Error impacted (i) selling, general and administrative expenses which impacted net income by $10.4 million, (ii) accrued and other liabilities by less than $0.1 million, and (iii) other long-term liabilities (which is included in accrued and other liabilities above) by less than $0.1 million. See description of the Error in the paragraphs above.